Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations.
about
An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study.A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis.
P2860
Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of darbepoetin alfa in the ...... armacoeconomic considerations.
@en
Use of darbepoetin alfa in the ...... armacoeconomic considerations.
@nl
type
label
Use of darbepoetin alfa in the ...... armacoeconomic considerations.
@en
Use of darbepoetin alfa in the ...... armacoeconomic considerations.
@nl
prefLabel
Use of darbepoetin alfa in the ...... armacoeconomic considerations.
@en
Use of darbepoetin alfa in the ...... armacoeconomic considerations.
@nl
P2860
P356
P1433
P1476
Use of darbepoetin alfa in the ...... armacoeconomic considerations.
@en
P2093
Fernando Carrera
Michel Burnier
P2860
P304
P356
10.1093/NDTPLUS/SFN175
P433
P577
2009-01-01T00:00:00Z